Cyterix Nabs $9.2M Round
Cyterix Pharmaceutics has landed $9.2 million from The Column Group and SV Life Sciences for its Series A Round. As part of the transaction, Tim Kutzkey, Ph.D., Partner at The Column Group, and Lutz Giebel, Ph.D., Managing Partner at SV Life Sciences, have joined the Cyterix Board of Directors. The company was founded in 2010.
7 June 2011•6 mins read
